Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

A PILOT STUDY OF A GRAPE SEED PROCYANIDIN EXTRACT FOR LUNG CANCER CHEMOPREVENTION.

Mao JT, Lu QY, Xue B, Neis P, Zamora FD, Lundmark L, Qualls C, Massie L.

Cancer Prev Res (Phila). 2019 May 28. pii: canprevres.0053.2019. doi: 10.1158/1940-6207.CAPR-19-0053. [Epub ahead of print]

PMID:
31138523
2.

Collision induced magnetic resonance in Cesium atoms.

Yang G, Zhang HB, Geng XX, Liang SQ, Zhu Y, Mao JT, Huang GM, Li GX.

Opt Express. 2018 Nov 12;26(23):30313-30323. doi: 10.1364/OE.26.030313.

PMID:
30469906
3.

Grape seed procyanidin extract against lung cancer: the role of microrna-106b, bioavailability, and bioactivity.

Xue B, Lu QY, Massie L, Qualls C, Mao JT.

Oncotarget. 2018 Feb 16;9(21):15579-15590. doi: 10.18632/oncotarget.24528. eCollection 2018 Mar 20.

4.

A Randomized Phase IIb Trial of myo-Inositol in Smokers with Bronchial Dysplasia.

Lam S, Mandrekar SJ, Gesthalter Y, Allen Ziegler KL, Seisler DK, Midthun DE, Mao JT, Aubry MC, McWilliams A, Sin DD, Shaipanich T, Liu G, Johnson E, Bild A, Lenburg ME, Ionescu DN, Mayo J, Yi JE, Tazelaar H, Harmsen WS, Smith J, Spira AE, Beane J, Limburg PJ, Szabo E; Cancer Prevention Network.

Cancer Prev Res (Phila). 2016 Dec;9(12):906-914. Epub 2016 Sep 22.

5.

Grape Seed Procyanidin Extract Mediates Antineoplastic Effects against Lung Cancer via Modulations of Prostacyclin and 15-HETE Eicosanoid Pathways.

Mao JT, Smoake J, Park HK, Lu QY, Xue B.

Cancer Prev Res (Phila). 2016 Dec;9(12):925-932. Epub 2016 Sep 22.

6.

MicroRNA-19a/b mediates grape seed procyanidin extract-induced anti-neoplastic effects against lung cancer.

Mao JT, Xue B, Smoake J, Lu QY, Park H, Henning SM, Burns W, Bernabei A, Elashoff D, Serio KJ, Massie L.

J Nutr Biochem. 2016 Aug;34:118-25. doi: 10.1016/j.jnutbio.2016.05.003. Epub 2016 May 20.

PMID:
27289489
7.

Tobacco smoking, NBS1 polymorphisms, and survival in lung and upper aerodigestive tract cancers with semi-Bayes adjustment for hazard ratio variation.

Yang T, Chang PY, Park SL, Bastani D, Chang SC, Morgenstern H, Tashkin DP, Mao JT, Papp JC, Rao JY, Cozen W, Mack TM, Greenland S, Zhang ZF.

Cancer Causes Control. 2014 Jan;25(1):11-23. doi: 10.1007/s10552-013-0303-0. Epub 2013 Oct 29.

8.

Chemoprevention of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Szabo E, Mao JT, Lam S, Reid ME, Keith RL.

Chest. 2013 May;143(5 Suppl):e40S-e60S. doi: 10.1378/chest.12-2348. Review.

9.

Green tea inhibits cycolooxygenase-2 in non-small cell lung cancer cells through the induction of Annexin-1.

Lu QY, Jin Y, Mao JT, Zhang ZF, Heber D, Dubinett SM, Rao J.

Biochem Biophys Res Commun. 2012 Nov 2;427(4):725-30. doi: 10.1016/j.bbrc.2012.09.125. Epub 2012 Oct 2.

10.

[Screening and identification of receptor reacting with nucleocapsid protein of duck enteritis virus].

hang H, Mao JT, Yang Y, Wang KG, Zhou BJ, Wen M.

Bing Du Xue Bao. 2012 Jan;28(1):63-6. Chinese.

PMID:
22416352
11.

Body mass index change in adulthood and lung and upper aerodigestive tract cancers.

Tarleton HP, Park SL, Zhu WM, Lee YC, Hashibe M, Morgenstern H, Tashkin DP, Mao JT, Cozen W, Mack TM, Zhang ZF.

Int J Cancer. 2012 Sep 15;131(6):1407-16. doi: 10.1002/ijc.27383. Epub 2012 Feb 9.

12.

[Expression and clinical significance of Nrf2 in esophageal squamous cell carcinoma].

Mao JT, Tangsakar E, Shen H, Wang ZQ, Zhang MX, Chen JX, Zhang G, Wang JS.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2011 Nov;27(11):1231-3. Chinese.

PMID:
22078454
13.

Lung cancer chemoprevention with celecoxib in former smokers.

Mao JT, Roth MD, Fishbein MC, Aberle DR, Zhang ZF, Rao JY, Tashkin DP, Goodglick L, Holmes EC, Cameron RB, Dubinett SM, Elashoff R, Szabo E, Elashoff D.

Cancer Prev Res (Phila). 2011 Jul;4(7):984-93. doi: 10.1158/1940-6207.CAPR-11-0078.

14.

Elevated levels of CXC chemokine connective tissue activating peptide (CTAP)-III in lung cancer patients.

Lee G, Gardner BK, Elashoff DA, Purcell CM, Sandha HS, Mao JT, Krysan K, Lee JM, Dubinett SM.

Am J Transl Res. 2011 May 15;3(3):226-33. Epub 2011 Apr 2.

15.

The Ninth Annual American Association of cancer research international conference on frontiers in cancer prevention research.

Xu L, Wang SS, Healey MA, Faupel-Badger JM, Wilken JA, Battaglia T, Szabo E, Mao JT, Bergan RC.

Cancer Prev Res (Phila). 2011 Apr;4(4):616-21. doi: 10.1158/1940-6207.CAPR-11-0018.

16.

Strategies for pacemaker programming in acute heart failure.

Lahiri MK, Mao JT, Schuger CD.

Heart Fail Rev. 2011 Sep;16(5):441-8. doi: 10.1007/s10741-011-9239-1. Review.

PMID:
21400230
17.

White tea extract induces apoptosis in non-small cell lung cancer cells: the role of peroxisome proliferator-activated receptor-{gamma} and 15-lipoxygenases.

Mao JT, Nie WX, Tsu IH, Jin YS, Rao JY, Lu QY, Zhang ZF, Go VL, Serio KJ.

Cancer Prev Res (Phila). 2010 Sep;3(9):1132-40. doi: 10.1158/1940-6207.CAPR-09-0264. Epub 2010 Jul 28.

18.

Associations between NBS1 polymorphisms, haplotypes and smoking-related cancers.

Park SL, Bastani D, Goldstein BY, Chang SC, Cozen W, Cai L, Cordon-Cardo C, Ding B, Greenland S, He N, Hussain SK, Jiang Q, Lee YC, Liu S, Lu ML, Mack TM, Mao JT, Morgenstern H, Mu LN, Oh SS, Pantuck A, Papp JC, Rao J, Reuter VE, Tashkin DP, Wang H, You NC, Yu SZ, Zhao JK, Zhang ZF.

Carcinogenesis. 2010 Jul;31(7):1264-71. doi: 10.1093/carcin/bgq096. Epub 2010 May 17.

19.

Cancer and inflammation: promise for biologic therapy.

Demaria S, Pikarsky E, Karin M, Coussens LM, Chen YC, El-Omar EM, Trinchieri G, Dubinett SM, Mao JT, Szabo E, Krieg A, Weiner GJ, Fox BA, Coukos G, Wang E, Abraham RT, Carbone M, Lotze MT.

J Immunother. 2010 May;33(4):335-51. doi: 10.1097/CJI.0b013e3181d32e74. Review.

20.

Single nucleotide polymorphisms of 8 inflammation-related genes and their associations with smoking-related cancers.

Oh SS, Chang SC, Cai L, Cordon-Cardo C, Ding BG, Greenland S, He N, Jiang Q, Kheifets L, Le A, Lee YC, Liu S, Lu ML, Mao JT, Morgenstern H, Mu LN, Pantuck A, Papp JC, Park SL, Rao JY, Reuter VE, Tashkin DP, Wang H, You NC, Yu SZ, Zhao JK, Belldegrun A, Zhang ZF.

Int J Cancer. 2010 Nov 1;127(9):2169-82. doi: 10.1002/ijc.25214.

21.

Eosinophil and T cell markers predict functional decline in COPD patients.

D'Armiento JM, Scharf SM, Roth MD, Connett JE, Ghio A, Sternberg D, Goldin JG, Louis TA, Mao JT, O'Connor GT, Ramsdell JW, Ries AL, Schluger NW, Sciurba FC, Skeans MA, Voelker H, Walter RE, Wendt CH, Weinmann GG, Wise RA, Foronjy RF.

Respir Res. 2009 Nov 19;10:113. doi: 10.1186/1465-9921-10-113.

22.

Conference Report: Seventh Annual AACR International Conference on Frontiers in Cancer Prevention Research.

Brown PH, Viner JL, Brewster A, Heckman CJ, Hursting S, Johnson K, Mao JT.

Cancer Prev Res (Phila). 2009 Nov;2(11):995-8. doi: 10.1158/1940-6207.CAPR-09-0128.

23.

Recruitment strategies for a lung cancer chemoprevention trial involving ex-smokers.

Kye SH, Tashkin DP, Roth MD, Adams B, Nie WX, Mao JT.

Contemp Clin Trials. 2009 Sep;30(5):464-72. doi: 10.1016/j.cct.2009.05.004. Epub 2009 Jun 7.

PMID:
19508900
24.

Differential modulation of leukotriene B4 synthesis and degradation in human bronchoalveolar lavage cells by lipopolysaccharide and tobacco smoke.

Mao JT, Tashkin DP, Tsu IH, Serio KJ.

Cancer Prev Res (Phila). 2008 Sep;1(4):266-74. doi: 10.1158/1940-6207.CAPR-08-0001.

25.

Focusing downstream in lung cancer prevention: 15-hydroxyprostaglandin dehydrogenase.

Dubinett SM, Mao JT, Hazra S.

Cancer Prev Res (Phila). 2008 Sep;1(4):223-5. doi: 10.1158/1940-6207.CAPR-08-0148. No abstract available.

26.

Meeting report: Sixth Annual AACR International Conference on Frontiers in Cancer Prevention Research.

Girnun GD, Howe LR, Manne S, Mao JT, Reid ME, Szabo E.

Cancer Prev Res (Phila). 2008 Jul;1(2):146-9. doi: 10.1158/1940-6207.CAPR-08-0023.

27.

Associations between variants of the 8q24 chromosome and nine smoking-related cancer sites.

Park SL, Chang SC, Cai L, Cordon-Cardo C, Ding BG, Greenland S, Hussain SK, Jiang Q, Liu S, Lu ML, Mao JT, Morgenstern H, Mu LN, Ng LJ, Pantuck A, Rao J, Reuter VE, Tashkin DP, You NC, Yu CQ, Yu SZ, Zhao JK, Belldegrun A, Zhang ZF.

Cancer Epidemiol Biomarkers Prev. 2008 Nov;17(11):3193-202. doi: 10.1158/1055-9965.EPI-08-0523.

28.

The partners--airflow obstruction, emphysema, and lung cancer.

Dubinett SM, Aberle DR, Tashkin DP, Mao JT.

Am J Respir Crit Care Med. 2008 Oct 1;178(7):665-6. doi: 10.1164/rccm.200806-902ED. No abstract available.

PMID:
18796652
29.

The Role of PPARgamma in the Cyclooxygenase Pathway in Lung Cancer.

Hazra S, Peebles KA, Sharma S, Mao JT, Dubinett SM.

PPAR Res. 2008;2008:790568. doi: 10.1155/2008/790568.

30.

Dietary flavonoid intake and lung cancer--a population-based case-control study.

Cui Y, Morgenstern H, Greenland S, Tashkin DP, Mao JT, Cai L, Cozen W, Mack TM, Lu QY, Zhang ZF.

Cancer. 2008 May 15;112(10):2241-8. doi: 10.1002/cncr.23398.

31.

Inflammation in lung carcinogenesis: new targets for lung cancer chemoprevention and treatment.

Lee JM, Yanagawa J, Peebles KA, Sharma S, Mao JT, Dubinett SM.

Crit Rev Oncol Hematol. 2008 Jun;66(3):208-17. doi: 10.1016/j.critrevonc.2008.01.004. Epub 2008 Mar 4. Review.

32.

A case-control study of the association of the polymorphisms and haplotypes of DNA ligase I with lung and upper-aerodigestive-tract cancers.

Lee YC, Morgenstern H, Greenland S, Tashkin DP, Papp J, Sinsheimer J, Cao W, Hashibe M, You NC, Mao JT, Cozen W, Mack TM, Zhang ZF.

Int J Cancer. 2008 Apr 1;122(7):1630-8.

33.

Inflammation and lung carcinogenesis: applying findings in prevention and treatment.

Peebles KA, Lee JM, Mao JT, Hazra S, Reckamp KL, Krysan K, Dohadwala M, Heinrich EL, Walser TC, Cui X, Baratelli FE, Garon E, Sharma S, Dubinett SM.

Expert Rev Anticancer Ther. 2007 Oct;7(10):1405-21. Review.

PMID:
17944566
34.

Lung cancer chemoprevention: ACCP evidence-based clinical practice guidelines (2nd Edition).

Gray J, Mao JT, Szabo E, Kelley M, Kurie J, Bepler G; American College of Chest Physicians.

Chest. 2007 Sep;132(3 Suppl):56S-68S.

PMID:
17873160
35.

Significance of cyclooxygenase-2 in prognosis, targeted therapy and chemoprevention of NSCLC.

Lee JM, Mao JT, Krysan K, Dubinett SM.

Future Oncol. 2007 Apr;3(2):149-53.

PMID:
17381414
36.

Feasibility of retinoids for the treatment of emphysema study.

Roth MD, Connett JE, D'Armiento JM, Foronjy RF, Friedman PJ, Goldin JG, Louis TA, Mao JT, Muindi JR, O'Connor GT, Ramsdell JW, Ries AL, Scharf SM, Schluger NW, Sciurba FC, Skeans MA, Walter RE, Wendt CH, Wise RA; FORTE Study Investigators.

Chest. 2006 Nov;130(5):1334-45.

PMID:
17099008
37.

TNF-alpha downregulates the leukotriene C4 synthase gene in mononuclear phagocytes.

Serio KJ, Luo C, Luo L, Mao JT.

Am J Physiol Lung Cell Mol Physiol. 2007 Jan;292(1):L215-22. Epub 2006 Sep 15.

38.

Celecoxib decreases Ki-67 proliferative index in active smokers.

Mao JT, Fishbein MC, Adams B, Roth MD, Goodglick L, Hong L, Burdick M, Strieter ER, Holmes C, Tashkin DP, Dubinett SM.

Clin Cancer Res. 2006 Jan 1;12(1):314-20.

39.

Chemoprevention strategies with cyclooxygenase-2 inhibitors for lung cancer.

Mao JT, Cui X, Reckamp K, Liu M, Krysan K, Dalwadi H, Sharma S, Hazra S, Strieter R, Gardner B, Dubinett SM.

Clin Lung Cancer. 2005 Jul;7(1):30-9. Review.

PMID:
16098242
40.

Gene expression changes in human small airway epithelial cells exposed to Delta9-tetrahydrocannabinol.

Sarafian T, Habib N, Mao JT, Tsu IH, Yamamoto ML, Hsu E, Tashkin DP, Roth MD.

Toxicol Lett. 2005 Aug 14;158(2):95-107. Epub 2005 Apr 26.

PMID:
16039398
41.

Modulation of pulmonary leukotriene B4 production by cyclooxygenase-2 inhibitors and lipopolysaccharide.

Mao JT, Tsu IH, Dubinett SM, Adams B, Sarafian T, Baratelli F, Roth MD, Serio KJ.

Clin Cancer Res. 2004 Oct 15;10(20):6872-8.

42.

Cyclooxygenase-2 modulates the insulin-like growth factor axis in non-small-cell lung cancer.

Põld M, Krysan K, Põld A, Dohadwala M, Heuze-Vourc'h N, Mao JT, Riedl KL, Sharma S, Dubinett SM.

Cancer Res. 2004 Sep 15;64(18):6549-55.

43.

Multifaceted roles of cyclooxygenase-2 in lung cancer.

Riedl K, Krysan K, Põld M, Dalwadi H, Heuze-Vourc'h N, Dohadwala M, Liu M, Cui X, Figlin R, Mao JT, Strieter R, Sharma S, Dubinett SM.

Drug Resist Updat. 2004 Jun;7(3):169-84. Review.

PMID:
15296859
44.

Cyclooxygenase-2-dependent expression of angiogenic CXC chemokines ENA-78/CXC Ligand (CXCL) 5 and interleukin-8/CXCL8 in human non-small cell lung cancer.

Põld M, Zhu LX, Sharma S, Burdick MD, Lin Y, Lee PP, Põld A, Luo J, Krysan K, Dohadwala M, Mao JT, Batra RK, Strieter RM, Dubinett SM.

Cancer Res. 2004 Mar 1;64(5):1853-60.

45.

Celecoxib modulates the capacity for prostaglandin E2 and interleukin-10 production in alveolar macrophages from active smokers.

Mao JT, Roth MD, Serio KJ, Baratelli F, Zhu L, Holmes EC, Strieter RM, Dubinett SM.

Clin Cancer Res. 2003 Dec 1;9(16 Pt 1):5835-41.

46.

All-trans retinoic acid modulates the balance of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in patients with emphysema.

Mao JT, Tashkin DP, Belloni PN, Baileyhealy I, Baratelli F, Roth MD.

Chest. 2003 Nov;124(5):1724-32.

PMID:
14605041
47.

Cyclooxygenase-2 in lung cancer.

Dubinett SM, Sharma S, Huang M, Dohadwala M, Pold M, Mao JT.

Prog Exp Tumor Res. 2003;37:138-62. Review. No abstract available.

PMID:
12795053
48.

A pilot study of all-trans-retinoic acid for the treatment of human emphysema.

Mao JT, Goldin JG, Dermand J, Ibrahim G, Brown MS, Emerick A, McNitt-Gray MF, Gjertson DW, Estrada F, Tashkin DP, Roth MD.

Am J Respir Crit Care Med. 2002 Mar 1;165(5):718-23.

PMID:
11874821
49.

Metastatic pancreatic cancer masquerading as pulmonary sarcoidosis.

Mao JT, Fisnbein MC.

Am J Med. 2000 Nov;109(7):598-9. No abstract available.

PMID:
11185477
50.

Double-orifice mitral valve with multiple papillary muscles--a report of two patients.

Mao JT, Tang J, Li Y, Sun P.

Angiology. 1999 Sep;50(9):771-5.

PMID:
10496505

Supplemental Content

Support Center